|Articles|September 29, 2015
PRA Collaborates on Vaccine Studies
Advertisement
PRA Health Sciences (PRA) announced a collaboration with the Alliance for Multispecialty Research (AMR) to improve the efficiency of vaccine studies. AMR is a network of independently owned, geographically diverse, and experienced Clinical Research Centers of Excellence and along with PRA’s vaccine experience in Phase I-IV trials will facilitate identification of appropriate vaccine study populations, as well as address subject retention and trial conduct in this area.
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Using AI Trial-Matching Tools to Accelerate Patient Access
September 8th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Using AI Trial-Matching Tools to Accelerate Patient Access
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
4
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
5